Otolaryngology Doctors in Glendale, AZ Accepting Medicare

10 Otolaryngology doctors found. Showing 1 - 10

Dr. David L Simms, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5750 W. Thunderbird Rd, Suite A-100, Glendale, AZ 85306 Phone: 602-938-3205    Fax: 602-938-5799

Dr. Gordon E Chait, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5750 W Thunderbird Rd, Ste. A-100, Glendale, AZ 85306 Phone: 602-938-3205    Fax: 602-938-5799

Sudhir P Agarwal, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5757 W Thunderbird Road, Suite W301, Glendale, AZ 85306 Phone: 602-938-3777    Fax: 602-547-0379

Elliot Martin Libling, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 18700 N 64th Dr, Ste 312, Glendale, AZ 85308 Phone: 623-566-4718    Fax: 623-566-4820

Michael Rodriguez, D.O. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 20325 N 51st Ave Ste 154, Glendale, AZ 85308 Phone: 623-900-4740    Fax: 855-398-9290

Ravi P Agarwal, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5757 W Thunderbird Rd, Suite W301, Glendale, AZ 85306 Phone: 602-938-3777    Fax: 602-547-0379

Stephanie Diana Warrington, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 5750 W Thunderbird Rd Ste A100, Glendale, AZ 85306 Phone: 602-938-3205    Fax: 602-938-5799

Ishrat Hakim, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 18700 N 64th Dr, Ste 312, Glendale, AZ 85308 Phone: 623-566-4718    Fax: 623-566-4820

Brandon Eugene Fornwalt, Otolaryngology Medicare: Medicare Enrolled Practice Location: 18699 N 67th Ave Ste 300, Glendale, AZ 85308 Phone: 623-566-4718    Fax: 523-566-4820

Jerald S Altman, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 18700 N 64th Dr, Ste 201, Glendale, AZ 85308 Phone: 623-566-4718    Fax: 623-566-4820

News Archive

Additional research needed for oral PrEP to treat HIV

The first human studies of an oral drug regimen to prevent HIV infection in high-risk individuals yielded a promising near 50% reduction in HIV incidence, but a number of issues require additional research before oral pre-exposure prophylaxis can be implemented on a large scale, according to an article in AIDS Patient Care and STDs, a peer-reviewed journal published by Mary Ann Liebert, Inc.

InfraReDx commences LipiScan IVUS System Phase 2 trial against heart attack

InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment of the first patient in its Phase 2 clinical trial, CANARY (Coronary Assessment by Near-infrared (NIR) of Atherosclerotic Rupture-prone Yellow).

Baxter, JW Holdings sign distribution, license agreement for omega 3 parenteral nutrition products

Baxter International Inc. and JW Holdings today announced that they have entered into an exclusive distribution and license agreement for parenteral nutritional products containing a novel formulation of omega 3 lipids.

New partnership aims to create stem cell resource to study psychiatric disorders

The New York Stem Cell Foundation and the Stanley Center at the Broad Institute of MIT and Harvard are partnering to create a foundational stem cell resource to study psychiatric disorders through the production of induced pluripotent stem (iPS) cell lines from individuals with schizophrenia and other psychiatric disorders.

Read more Medical News

› Verified 4 days ago